Document Detail

Letter: Primary cutaneous marginal zone B cell lymphoma of the face: a challenging diagnosis.
MedLine Citation:
PMID:  22398233     Owner:  NLM     Status:  MEDLINE    
The primary cutaneous marginal zone B cell lymphoma is a small B cell lymphoma, including cells of the marginal zone, lymphoplasmacytic cells, and plasma cells. Clinically it manifests as erythematous or erythematous-violaceous papules, plaques, or nodules, single or multiple, most often located to the extremities. Its course is usually indolent, with a survival at 5 years of approximately 97 percent. The tumor exhibits a tendency towards local recurrence, but spread to locations outside the skin is extremely rare. We present a case report of a man, 80 years of age, with a primary cutaneous marginal B cell lymphoma of the chin, an atypical location.
Ana Oliveira; Mónica Caetano; Rosário Alves; Margarida Lima; Manuela Selores
Related Documents :
22824083 - The early phase of human sepsis is characterized by a combination of apoptosis and prol...
19200803 - Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells.
2184263 - Diagnostic and therapeutic technology assessment. prophylactic treatment for opportunis...
Publication Detail:
Type:  Case Reports; Letter     Date:  2012-02-15
Journal Detail:
Title:  Dermatology online journal     Volume:  18     ISSN:  1087-2108     ISO Abbreviation:  Dermatol. Online J.     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-03-08     Completed Date:  2012-07-17     Revised Date:  2012-10-04    
Medline Journal Info:
Nlm Unique ID:  9610776     Medline TA:  Dermatol Online J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  12     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Antigens, CD20 / analysis
Antineoplastic Agents / therapeutic use
Facial Neoplasms / diagnosis*,  drug therapy,  pathology
Interferon-alpha / therapeutic use
Lymphoma, B-Cell, Marginal Zone / diagnosis*,  drug therapy,  pathology
Proto-Oncogene Proteins c-bcl-2 / analysis
Reg. No./Substance:
0/Antigens, CD20; 0/Antineoplastic Agents; 0/Interferon-alpha; 0/Proto-Oncogene Proteins c-bcl-2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Lichen planus pigmentosus-inversus: case report and review of an unusual entity.
Next Document:  Letter: Allergic contact dermatitis from sculptured acrylic nails: special presentation with a possi...